Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Millennium to submit Velcade NDA and MAA filings by early 2003

Dec. 10, 2002

huN901-DM1 enters phase II portion of U.S. SCLC study

Dec. 10, 2002

Corixa and Kirin collaborate on WT1 cancer vaccine development

Dec. 9, 2002

Apoptosis-inducing hydrazones as novel antitumor agents

Dec. 9, 2002

Vertex researchers describe novel series of ERK inhibitors

Dec. 9, 2002

CeMines and CePeP enter pilot program for peptide-based cancer drugs

Dec. 9, 2002

No cytotoxic effect reported for seocalcitol monotherapy in pancreatic cancer

Dec. 9, 2002

High response rate found for temozolomide plus celecoxib in recurrent malignant glioma

Dec. 9, 2002

Allos to begin rolling NDA submission for RSR-13

Dec. 5, 2002

Swissmedic approves Glivec for first-line treatment of CML

Dec. 5, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...